ArticleTransboundary and emerging diseases2025
Recombinant CA Protein-Based ELISA for Serological Detection of Small Ruminant Lentiviruses Antibodies.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maedi-visna (MV) and caprine arthritis encephalitis (CAE) are important viral diseases of sheep and goats. The diseases are caused by a group of genetically closely related lentiviruses known as small ruminant lentiviruses (SRLV), and are collectively referred to as SRLV infections. As the majority of sheep and goats infected with SRLV are asymptomatic, the disease is often overlooked. However, SRLV infection can significantly reduce animal productivity and impede animal trade. Currently, SRLV infection is widespread worldwide, but knowledge of its prevalence in China is limited due to a lack of cost-effective testing. In this study, we successfully developed an indirect enzyme-linked immunosorbent assay (iELISA) based on the SRLV capsid protein (CA) (p28) for the specific detection of anti-SRLV antibodies in serum. Using the application of checkerboard titration to optimize the iELISA assay conditions, the cut-off value was determined to be 0.09 by analyzing S/P values of 181 negative sera against SRLV that were confirmed with western blotting (WB). The method showed good reproducibility, with intra- and inter-assay coefficients of variation (CV) values less than 6.60%. A specificity test showed that the iELISA had no serological cross-reaction with six common small ruminant pathogens. Moreover, it was found to be 400-1600 times more sensitive than the available AGID test. The 93 clinical serum samples that tested SRLV-positive using the iELISA were all confirmed as positive using WB, indicating that the method has a low false positive rate. The iELISA was then applied to assess 4786 clinical serum samples from 13 cities in six provinces in China. The results show that the SRLV positivity rate of sera ranged between 0.85% and 40.00%, with the overall seroprevalence of SRLV being 10.64%. Our results indicate that the developed iELISA will serve as a valuable and efficient screening tool for the large-scale preliminary surveillance and monitoring of SRLV infections in both sheep and goats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.